Carol F. Lippa

Active 1990–2024

56
Papers
19,797
Citations
52
h-index
55
i10-index

Citations

Citations per year for Carol F. Lippa1967: 1 citations1992: 4 citations1993: 3 citations1994: 8 citations1995: 21 citations1996: 27 citations1997: 37 citations1998: 24 citations1999: 39 citations2000: 85 citations2001: 69 citations2002: 72 citations2003: 88 citations2004: 90 citations2005: 58 citations2006: 131 citations2007: 151 citations2008: 192 citations2009: 239 citations2010: 196 citations2011: 230 citations2012: 218 citations2013: 186 citations2014: 253 citations2015: 228 citations2016: 228 citations2017: 241 citations2018: 266 citations2019: 798 citations2020: 784 citations2021: 680 citations2022: 553 citations2023: 422 citations2024: 666 citations2025: 335 citations2026: 3 citations1968–1991: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,910 citing papers, 26.7% of this breakdownUnited Kingdom: 1,220 citing papers, 11.2% of this breakdownItaly: 630 citing papers, 5.8% of this breakdownGermany: 606 citing papers, 5.6% of this breakdownJapan: 516 citing papers, 4.7% of this breakdownCanada: 471 citing papers, 4.3% of this breakdownChina: 419 citing papers, 3.9% of this breakdownSpain: 415 citing papers, 3.8% of this breakdownNetherlands: 389 citing papers, 3.6% of this breakdownSweden: 362 citing papers, 3.3% of this breakdownFrance: 344 citing papers, 3.2% of this breakdownAustralia: 319 citing papers, 2.9% of this breakdown
0%26.7%Other 21%

Fields

  • Medicine73.5%
  • Neuroscience12.3%
  • Biochemistry, Genetics and Molecular Biology10.9%
  • Psychology0.7%
  • Immunology and Microbiology0.5%
  • Health Professions0.4%
  • Other1.7%

Topics

  • Alzheimer's disease research and treatments14.3%
  • Parkinson's Disease Mechanisms and Treatments10.9%
  • Dementia and Cognitive Impairment Research9.7%
  • Amyotrophic Lateral Sclerosis Research5%
  • Neurological disorders and treatments3.4%
  • Neuroinflammation and Neurodegeneration Mechanisms2.6%
  • Other54.1%

Coauthors

All papers

Open in search
  1. Diagnosis and management of dementia with Lewy bodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Álex Iranzo, Kejal Kantarci, Daniel Kaufer, Walter A. Kukull, Virginia M.‐Y. Lee, James B. Leverenz, Simon J.G. Lewis, Carol F. Lippa, Angela Lunde, Mario Masellis, Eliezer Masliah, Pamela J. McLean, Brit Mollenhauer, Thomas J. Montine, Emilio Moreno, Etsuro Mori, Melissa E. Murray, John T. O’Brien, Sotoshi Orimo, Ronald B. Postuma, Shankar Ramaswamy, Owen A. Ross, David P. Salmon, Andrew Singleton, Angela Taylor, Alan Thomas, Pietro Tiraboschi, Jon B. Toledo, John Q. Trojanowski, Debby W. Tsuang, Zuzana Walker, Masahito Yamada, Kenji Kosaka - Neurology 2017 cited by 4,446

  2. Diagnosis and management of dementia with Lewy bodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kenji Kosaka, V.M.Y. Lee, Andrew J. Lees, Irene Litvan, Elisabet Londos, Oscar L. López, Satoshi Minoshima, Y Mizuno, J. A. Molina, Elizabeta B. Mukaetova‐Ladinska, Florence Pasquier, R. H. Perry, Jörg B. Schulz, John Q. Trojanowski, Masahito Yamada - Neurology 2005 cited by 5,057

  3. TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zbigniew K. Wszołek, Elizabeth Finger, Carol F. Lippa, David Lacomis, Heather Stewart, Dennis W. Dickson, Hong Joo Kim, Ekaterina Rogaeva, Eileen H. Bigio, Khrista Boylan, J. Paul Taylor, Rosa Rademakers - Neuron 2017 cited by 651

  4. Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration

    Authors: , , , , , , , , , , , , , - Journal of Neuropathology & Experimental Neurology 2002 cited by 718

  5. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dennis W. Dickson, Rosa Rademakers, Owen A. Ross - Molecular Neurodegeneration 2013 cited by 413

  6. Lewy Bodies Contain Altered α-Synuclein in Brains of Many Familial Alzheimer's Disease Patients with Mutations in Presenilin and Amyloid Precursor Protein Genes

    Authors: , , , , , , , , , , , , , , , , - American Journal Of Pathology 1998 cited by 535

  7. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , José Brás, Sotoshi Orimo, Mario Masellis, Alan Thomas, Álex Iranzo, Kejal Kantarci, John T. O’Brien, Omar M. A. El‐Agnaf, Bradley F. Boeve, James B. Leverenz, Jon B. Toledo, John E. Duda, Dag Aarsland, David J. Burn, Dennis W. Dickson, Hiroshige Fujishiro, John‐Paul Taylor, F. Blanc, Melissa E. Murray, Brit Mollenhauer, David P. Salmon, Laura Bonanni, Ronald B. Postuma, Emilio Moreno, Virginia M.‐Y. Lee, Debby W. Tsuang, Neill R. Graff‐Radford, Tanis J. Ferman, Douglas Galasko, Patrik Brundin, Simon J.G. Lewis, Zuzana Walker, Ian G. McKeith - 2017 cited by 379

  8. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ian R. Mackenzie, Bruce L. Miller, Bradley F. Boeve, Steven G. Younkin, Dennis W. Dickson, Ronald C. Petersen, Neill R. Graff‐Radford, Daniel H. Geschwind, Rosa Rademakers - Neurology 2010 cited by 247

  9. TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ian R. Mackenzie, William W. Seeley, Lea T. Grinberg, Bruce L. Miller, Khrista Boylan, Neill R. Graff‐Radford, Bradley F. Boeve, Dennis W. Dickson, Rosa Rademakers - Acta Neuropathologica 2014 cited by 158

  10. Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rosa Rademakers - PLoS Genetics 2008 cited by 463

  11. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter Johannsen, Jørgen E. Nielsen, Yingxue Ren, Marka van Blitterswijk, Mariely DeJesus‐Hernandez, Elizabeth Christopher, Melissa E. Murray, Kevin F. Bieniek, Bret M. Evers, Camilla Ferrari, Sara Rollinson, Anna Richardson, Elio Scarpini, Giorgio Fumagalli, Alessandro Padovani, John Hardy, Parastoo Momeni, Raffaele Ferrari, Francesca Frangipane, Raffaele Maletta, Maria Anfossi, Maura Gallo, Leonard Petrucelli, EunRan Suh, Oscar L Lopez, Tsz Hang Wong, Jeroen van Rooij, Harro Seelaar, Simon Mead, Richard J. Caselli, Eric M. Reiman, Marwan N. Sabbagh, Mads Kjølby, Anders Nykjær, Anna M. Karydas, Adam L. Boxer, Lea T. Grinberg, Jordan Grafman, Salvatore Spina, Adrian L. Oblak, M-Marsel Mesulam, Sandra Weıntraub, Changiz Geula, John R. Hodges, Olivier Piguet, William S. Brooks, David J. Irwin, John Q. Trojanowski, Edward B. Lee, Keith A. Josephs, Joseph E. Parisi, Nilüfer Ertekin‐Taner, David S. Knopman, Benedetta Nacmias, Irene Piaceri, Silvia Bagnoli, Sandro Sorbi, Marla Gearing, Jonathan D. Glass, Thomas G. Beach, Sandra E. Black, Mario Masellis, Ekaterina Rogaeva, Jean‐Paul Vonsattel, Lawrence S. Honig, Julia Kofler, Amalia C. Bruni, Julie S. Snowden, David Mann, Stuart Pickering‐Brown and 33 more - The Lancet Neurology 2018 cited by 129

  12. Dementia with Lewy bodies

    Authors: , , , , , , , , , , , , , , , , , - The Lancet Neurology 2003 cited by 612

  13. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal system

    Authors: , , , , , , , - Neuron 1995 cited by 377

  14. DLB and PDD boundary issues

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John Q. Trojanowski, Zbigniew K. Wszołek - Neurology 2007 cited by 549

  15. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carol F. Lippa, Eileen H. Bigio, Ian R. Mackenzie, Elizabeth Finger, Andrew Kertesz, Richard J. Caselli, Marla Gearing, Jorge L. Juncos, Bernardino Ghetti, Salvatore Spina, Yvette Bordelon, Wallace W. Tourtellotte, Matthew P. Frosch, Jean Paul Vonsattel, Chris Zarow, Thomas G. Beach, Roger L. Albin, Andrew P. Lieberman, Virginia M. Lee, John Q. Trojanowski, Vivianna M. Van Deerlin, Thomas D. Bird, Douglas Galasko, Eliezer Masliah, Charles L. White, Juan C. Troncoso, Didier Hannequin, Adam L. Boxer, Michael D. Geschwind, Satish Kumar, Eva‐Maria Mandelkow, Zbigniew K. Wszołek, Ryan J. Uitti, Dennis W. Dickson, Jonathan L. Haines, Richard Mayeux, Margaret A. Pericak‐Vance, Lindsay A. Farrer, Owen A. Ross, Rosa Rademakers, Gerard D. Schellenberg, Bruce L. Miller, Eckhard Mandelkow, Daniel H. Geschwind - Human Molecular Genetics 2012 cited by 236

  16. Lewy body dementia: The caregiver experience of clinical care

    Authors: , , , , , - Parkinsonism & Related Disorders 2010 cited by 153

  17. Association of CSF α-Synuclein Seeding Amplification Assay Results With Clinical Features of Possible and Probable Dementia With Lewy Bodies

    Authors: , , , , , , , , , , , , , , , , , , , , - Neurology 2024 cited by 43

  18. Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Neuroscience 2007 cited by 395

  19. Antibodies to ?-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease

    Authors: , , , - Annals of Neurology 1999 cited by 295

  20. Association of β-Amyloid Burden With Sleep Dysfunction and Cognitive Impairment in Elderly Individuals With Cognitive Disorders

    Authors: , , , , , , - JAMA Network Open 2019 cited by 51

  21. Transactive Response DNA-Binding Protein 43 Burden in Familial Alzheimer Disease and Down Syndrome

    Authors: , , , , , - Archives of Neurology 2009 cited by 81

  22. ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2023 cited by 20

  23. Lewy Bodies in the Amygdala

    Authors: , , , - Archives of Neurology 2004 cited by 119

  24. Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lea T. Grinberg, Bruce L. Miller, Khrista Boylan, Neill R. Graff‐Radford, Bradley F. Boeve, Dennis W. Dickson, Rosa Rademakers - Neurobiology of Aging 2014 cited by 99